Characteristics of the patients
| Characteristic . | Value . | Value . |
|---|---|---|
| Training dataset . | Validation . | |
| No. of patients | 86 | 181 |
| Male sex, no. of patients (%) | 55 (64) | 107 (59) |
| Rai stage | ||
| 0-II | 60 (70) | 154 (85) |
| III-IV | 9 (10) | 6 (3) |
| No data | 17 (20) | 21 (12) |
| Age at diagnosis, y | ||
| Median | 56 | 56 |
| Range | 34-78 | 34-81 |
| ZAP-70 expression | ||
| ZAP-70 negative (0% to 20%) | 41 (48) | 110 (61) |
| ZAP-70 positive (>20%) | 45 (52) | 71 (39) |
| IGHV | ||
| Unmutated (≥98% homology) | 43 (50) | 81 (45) |
| Mutated (<98%homology) | 43 (50) | 100 (55) |
| Characteristic . | Value . | Value . |
|---|---|---|
| Training dataset . | Validation . | |
| No. of patients | 86 | 181 |
| Male sex, no. of patients (%) | 55 (64) | 107 (59) |
| Rai stage | ||
| 0-II | 60 (70) | 154 (85) |
| III-IV | 9 (10) | 6 (3) |
| No data | 17 (20) | 21 (12) |
| Age at diagnosis, y | ||
| Median | 56 | 56 |
| Range | 34-78 | 34-81 |
| ZAP-70 expression | ||
| ZAP-70 negative (0% to 20%) | 41 (48) | 110 (61) |
| ZAP-70 positive (>20%) | 45 (52) | 71 (39) |
| IGHV | ||
| Unmutated (≥98% homology) | 43 (50) | 81 (45) |
| Mutated (<98%homology) | 43 (50) | 100 (55) |